Simplicity Solutions LLC Acquires 598 Shares of UiPath Inc. (NYSE:PATH)

Simplicity Solutions LLC lifted its holdings in shares of UiPath Inc. (NYSE:PATH) by 4.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,691 shares of the healthcare company’s stock after purchasing an additional 598 shares during the period. Simplicity Solutions LLC’s holdings in UiPath were worth $315,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in PATH. Raymond James Financial Services Advisors Inc. boosted its position in shares of UiPath by 3.8% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 40,993 shares of the healthcare company’s stock valued at $885,000 after purchasing an additional 1,506 shares in the last quarter. MetLife Investment Management LLC acquired a new position in UiPath during the 1st quarter worth approximately $184,000. BlackRock Inc. raised its stake in UiPath by 1.9% during the 1st quarter. BlackRock Inc. now owns 5,316,635 shares of the healthcare company’s stock worth $114,786,000 after buying an additional 99,242 shares during the period. Dimensional Fund Advisors LP acquired a new position in UiPath during the 1st quarter worth approximately $534,000. Finally, Canada Pension Plan Investment Board acquired a new position in UiPath during the 1st quarter worth approximately $259,000. Institutional investors own 62.50% of the company’s stock.

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $22.84, for a total transaction of $365,440.00. Following the completion of the transaction, the chief financial officer now directly owns 87,505 shares of the company’s stock, valued at $1,998,614.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Over the last ninety days, insiders sold 72,000 shares of company stock valued at $1,591,360. Company insiders own 31.03% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the company. Evercore ISI upped their price target on UiPath from $24.00 to $27.00 and gave the stock an “in-line” rating in a research note on Thursday, March 14th. Canaccord Genuity Group upped their price target on UiPath from $27.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, March 15th. KeyCorp started coverage on UiPath in a research note on Monday, April 8th. They issued an “overweight” rating and a $27.00 price objective for the company. DA Davidson increased their price objective on UiPath from $20.00 to $24.00 and gave the stock a “neutral” rating in a research note on Thursday, March 14th. Finally, William Blair started coverage on UiPath in a research note on Tuesday, January 2nd. They issued an “outperform” rating for the company. Nine analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $27.41.

UiPath Stock Down 1.6 %

Shares of PATH opened at $18.74 on Friday. The stock has a 50 day moving average of $22.82 and a 200 day moving average of $21.45. UiPath Inc. has a 12 month low of $12.38 and a 12 month high of $27.87.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The business had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. Research analysts predict that UiPath Inc. will post -0.04 earnings per share for the current year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.